CYP2C19 and stroke disorder: Some studies suggested that for carriers of CYP2C19 LoFA with ESRS ≥3, clopidogrel combined with aspirin for TIA or acute cerebral infarction could still significantly reduce 90-day stroke recurrence and the incidence of combined vascular events compared with aspirin alone [11].